Johnson & Johnson's Ebola vaccine to be used in Congo | Fin24
  • Data Market Inquiry

    MTN says it is prepared to defend itself before Competition Tribunal over report.

  • Claims of sabotage

    What we know so far about allegations of sabotage at an Eskom power station.

  • Dudu Myeni

    Court dismisses former SAA chiar's bid to have Outa withdraw from delinquency case.


Johnson & Johnson's Ebola vaccine to be used in Congo

Oct 13 2019 07:35
Michael J. Kavanagh

The Democratic Republic of Congo will distribute a second vaccination for Ebola from Johnson & Johnson at the beginning of November.

The vaccine will first be distributed to two communes in Goma, the trading hub on the border with Rwanda, Dr. Jean-Jacques Muyembe, the head of the country’s Ebola response effort, told reporters Saturday in the capital, Kinshasa. More than 64,000 people cross the border there each day, he said.

Johnson & Johnson will progressively ship about 200,000 doses of the vaccine to Rwanda and another 500,000 to Congo starting October 18, Muyembe said.

“Our goal is to create an immunological curtain that will prevent the virus from leaving the infected zone to the uninfected zone,” he said.

The Ebola outbreak, which was first announced in August 2018, has killed 2,146 people as of October 10. Another vaccine manufactured by Merck & Co., has already been given to more than 230,000 people since August 2018.



Company Snapshot

Voting Booth

How concerned are you about ransomware attacks?

Previous results · Suggest a vote